High Clinical Response Rate with Multimodality Immunomodulatory Therapy for Sézary Syndrome
Authors:
- Julie H. LinJLJulie H. Lin
- Carmela C. VittorioCVCarmela C. Vittorio
- Ellen J. KimEKEllen J. Kim
- Jessica S. YoonJYJessica S. Yoon
- Jacqueline Junkins-HopkinsJJJacqueline Junkins-Hopkins
- Alain H. RookARAlain H. Rook
- 1 November 2006
- journal article
- clinical trial
- Published by Elsevier in Clinical Lymphoma Myeloma and Leukemia
- Vol. 7 (3) , 226-232
Abstract
No abstract availableKeywords
This publication has 42 references indexed in Scilit:
- Interleukin 4 and interferon‐γ expression of the dermal infiltrate in patients with erythroderma and mycosis fungoides. An immuno‐histochemical studyJournal of Cutaneous Pathology, 2000
- Inflammatory Skin Diseases, T Cells, and Immune SurveillanceNew England Journal of Medicine, 1999
- Abnormal Clones of T Cells Producing Interleukin-5 in Idiopathic EosinophiliaNew England Journal of Medicine, 1999
- Prognosis in cutaneous T-cell lymphoma by skin stage: Long-term survival in 489 patientsJournal of the American Academy of Dermatology, 1999
- Clinical Characteristics and Long-term Outcome of Patients With Generalized Patch and/or Plaque (T2) Mycosis FungoidesArchives of Dermatology, 1999
- Interleukin 10 (IL-10) inhibits human lymphocyte interferon gamma-production by suppressing natural killer cell stimulatory factor/IL-12 synthesis in accessory cells.Journal of Experimental Medicine, 1993
- The Immunopathogenesis of Cutaneous T-Cell LymphomaArchives of Dermatology, 1993
- Aberrant Cytokine Production By Sezary Syndrome Patients: Cytokine Secretion Pattern Resembles Murine Th2 CellsJournal of Investigative Dermatology, 1992
- Recombinant interleukin 4 suppresses the production of interferon gamma by human mononuclear cells.Journal of Experimental Medicine, 1989
- Cutaneous T cell lymphoma: Mycosis fungoides, Sézary syndrome, and other variantsJournal of the American Academy of Dermatology, 1980